Access to Medicine Foundation

NOW ONLINE: The 2026 AMR Benchmark #AMRB26 finds pockets of progress in how #pharma companies are tackling #AMR but #DrugResistance continues to outpace industry-wide efforts, underscoring the urgent need for more comprehensive action. Read the report 👉 accesstomedicinefoundation.org/news/tools-to-…

Key findings from #AMRB26 show both progress & missed opportunities in the industry’s response to #AMR. Innovation remains limited, access to existing #antibiotics is uneven & action still falls short of the scale needed. Read the report's key findings👉tinyurl.com/4mkxh3wx

How is the #pharma industry performing in the fight against #AMR? #AMRB26 presents a mixed picture. While some companies are making progress in specific areas, overall industry performance has declined since 2021 & progress remains uneven. Learn more👉 accesstomedicinefoundation.org/insights-resou…

Over 80% of deaths linked to #AMR occur in #LMICs, where access to effective #antibiotics & #healthcare is often limited. Understanding what drives #AntimicrobialResistance & how to curb its spread is key to protecting modern medicine. Learn more👉…rk2026.accesstomedicinefoundation.org

Discussions at yesterday’s #AMRB26 launch in London highlighted the fragility of the #AMR landscape. Participants emphasised that stronger partnerships, coordinated incentives & responsible use of #antibiotics will be key to sustaining progress. 🔗accesstomedicinefoundation.org/news/tools-to-…

@AMRInvestAction; @FAIRRInitiative; @DHSCgovuk

@FCDOGovUK; @wellcometrust; @AfricaCDC; @Amref_Worldwide; @FlemingCentre; @gardp_amr; @ECSA_HC; @ICARS_global; @gstrategylab; @WHO; @ehealthpaho; @CARB_X; @MSCI_Inc; @MorningstarInc; @LSEGplc; @SPGMarketIntel; @Sustainalytics; @FTSERussell

NOW ONLINE: The 2026 AMR Benchmark #AMRB26 finds pockets of progress in how #pharma companies are tackling #AMR but #DrugResistance continues to outpace industry-wide efforts, underscoring the urgent need for more comprehensive action. Read the report 👉 accesstomedicinefoundation.org/news/tools-to-…

COMING SOON: How is the #pharma industry responding to the growing threat of #AMR? The 2026 AMR Benchmark #AMRB26, coming out tomorrow, assesses how 25 companies are addressing AMR, highlighting progress & remaining gaps. Read the methodology➡️ accesstomedicinefoundation.org/news/new-metho…

Since 2017, the Foundation has tracked how #pharma companies address #AntimicrobialResistance across four Benchmark editions & research reports, analysing action in R&D, responsible manufacturing & access & stewardship. Explore our research on #AMR👉tinyurl.com/yc8688u6

To mark the launch of the 2026 #AMR Benchmark, we're co-hosting a high-level forum with @FlemingCentre on 10 March to revisit 2024 UN AMR commitments & explore how the Benchmark can drive stronger partnerships & faster industry action. Learn more👉accesstomedicinefoundation.org/event/foundati…

Since 2017, the Foundation has tracked how industry responds to #AMR & where stronger action is needed. Through the AMR Benchmark & thematic reports, we provide data & analyses to inform #GlobalHealth decision-making. Learn more👉accesstomedicinefoundation.org/cross-sector-p… #AntimicrobialResistance

#AMR is one of the most urgent threats to #GlobalHealth. Without decisive action, the medicines we rely on risk becoming ineffective, putting growing pressure on #HealthSystems. Tackling AMR requires sustained, cross-sector action. Learn more👉accesstomedicinefoundation.org/cross-sector-p…

In her latest op-ed for @wef, our CEO, @JayasreeKIyer, explores how #AI could help bridge #healthcare gaps worldwide & what must happen to ensure it benefits everyone, not just the well-resourced. Read more ➡️ accesstomedicinefoundation.org/in-the-media/o… #Access2Meds #HealthEquity #GlobalHealth

This week, our CEO @JayasreeKIyer is attending the #AMR 2026 Summit in Sydney, where she'll join a panel on investor action & AMR & take part in a keynote session on how environmental requirements affect smaller antibiotic manufacturers. Learn more ➡️accesstomedicinefoundation.org/event/jayasree…

Are you a keen writer & editor who thrives on crafting crisp, clear prose? Join our team & work closely with our policy experts & researchers to help shape & structure findings & insights into digestible texts➡️accesstomedicinefoundation.org/writer-editor #hiring #HiringAlert #NGOJobs #AmsterdamJobs

#HiringNow 📣 We’re looking for a Researcher to support analytical work across our programmes, assessing how #healthcare companies address #Access2Meds & turning data into insights that inform our work. Learn more & apply now➡️accesstomedicinefoundation.org/researcher #hiring #vacancy #NGOJobs

🎗️“On World Cancer Day, let’s commit to turning innovation into impact and hope into access—for everyone, everywhere.” — @JayasreeKIyer (@AtMIndex) #OncoThon #GlobalOncoThon2026 #OncoDaily #WorldCancerDay #CancerEquity

In recognition of #WorldCancerDay, we’re looking back at an episode of The #HealthEquity Podcast featuring Dr Fatima Cardoso of @ABCGlobalAll, in conversation w/ our CEO @JayasreeKIyer on advancing equity in #CancerCare for women in #LMICs. Listen here➡️accesstomedicinefoundation.org/the-health-equ…

#NTDs affect 1B+ people worldwide, mostly in underserved communities. Gaps in #Access2Meds mean many are still left behind. #WorldNTDDay is a moment to reflect on what’s needed to close these gaps, including stronger action from the industry. Learn more➡️accesstomedicinefoundation.org/healthcare-ine…

Antimalarial resistance is rising, & children in Africa are at greatest risk. With treatments losing effectiveness & funding under pressure, decades of progress are under threat. Our latest industry analysis shows how companies can take meaningful action➡️accesstomedicinefoundation.org/access-insight…